CareDx to acquire oncology diagnostics company Naveris for up to $260 million

BRISBANE: CareDx Inc. has agreed to acquire precision oncology diagnostics company Naveris for up to $260 million, expanding its testing services beyond transplant medicine into cancer monitoring. The deal includes…

Muhammad ALI April 29, 2026

Euronext

bioMérieux buys Accellix to boost cell and gene therapy quality control

PARIS: French diagnostics group bioMérieux said on Thursday it has acquired U.S.-based Accellix, a developer of rapid, automated flow cytometry platforms, in a deal worth around €35 million. The acquisition…

NNR January 22, 2026

Australian Exchange

Proteomics International names David Morris as CEO

SYDNEY: Proteomics International Laboratories Ltd (ASX: PIQ) announced on Wednesday the appointment of David Morris as Chief Executive Officer and Managing Director, effective January 19, 2026. Morris succeeds founder Dr.…

NNR January 14, 2026

London Stock Exchange

BATM to sell its diagnostic distribution business in Romania for £17.6 million

LONDON: BATM (LSE: BVC; TASE: BVC), a global provider of advanced network infrastructure, cybersecurity and diagnostic technologies, has entered into an agreement to sell A.M.S 2000 Trading Impex SRL (AMS),…

NNR October 6, 2025

London Stock Exchange

BATM reports interim results with strategic progress across core divisions

Revenue rose to $60.4 million from $58.9 million a year earlier LONDON: BATM Advanced Communications Ltd. (LSE: BVC; TASE: BVC), a global provider of network infrastructure, cybersecurity and diagnostic technologies,…

NNR August 18, 2025

London Stock Exchange

BATM divests three non-core units to sharpen focus on core technologies

LONDON: BATM Advanced Communications Ltd. (LSE: BVC; TASE: BVC) said Wednesday it has sold three of its non-core businesses, part of an ongoing strategy to streamline operations and concentrate on…

NNR July 24, 2025

Wire

Agilent Technologies names Padraig McDonnell as next CEO

Agilent Technologies Inc. (NYSE: A) announced today that Padraig McDonnell, the current president of the Agilent CrossLab Group (ACG) and chief commercial officer, will succeed Mike McMullen as the company’s…

NNR February 22, 2024

Euronext

Theradiag launches €5.3 million rights issue

PARIS, FRANCE: Theradiag, a company specializing in in vitro diagnostics and Theranostics, announced the launch of a rights issue for a target amount of €5.3 million issuing 4.37 million shares…

NNR October 26, 2021